RISK FACTORS FOR ATHEROSCLEROSIS IN OBESE CHILDREN  Dyslipidemia High triglycerides, VLDL Low HDL High small, dense LDL  Glucose intolerance, diabetes.

Slides:



Advertisements
Similar presentations
Type 2 Diabetes – An Overview
Advertisements

Long-term Complications of Type 2 Diabetes
C-Reactive Protein: What Is It?  Marker of inflammation made in liver 1  Acute-phase response  Illness or injury 2  Adipocyte release of cytokines.
DO YOU HAVE THE METABOLIC SYNDROME? You're never too young to have it Jacqueline A. Eberstein, R.N.
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
1 The Atkins Nutritional Approach is an Effective Tool for Treating Metabolic Syndrome X A GP’s perspective Dr Sarah Brewer.
The Healthy Heart Figure 14.1.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
More Facts on Fats Lipids and Health.
Metabolism of Carbohydrates: Implications for Health Janine Higgins, PhD University of Colorado Denver.
Presentation Package for Concepts of Physical Fitness 14e
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Chapter 11 Diet and Health
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Lesson 1 What is Coronary Artery Disease? Coronary Artery Disease also known as Coronary Heart Disease.
Healthy eating for middle-years Professor Tom Sanders Nutritional Sciences Division.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
+ Were Hunters and Gatherers Really Healthier Than Us? An Evidence Based Look at the Paleolithic Diet By: Kelsey Starck.
Lindsay Haney.
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
B LOOD C HEMISTRY How it affects Cardiovascular Disease.
Metabolic Syndrome. America’s Health Status one-third of U.S. adults (35.7%) are obese. 17% (12.5 million) of children 2—19 years are obese. Top leading.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
MI: Risk Factors and Primary Prevention. Risk Factors Factors that appear to increase the general population’s chances of experiencing a health problem.
Note Final Exam-please check final schedule Essays due-lateness unacceptable.
Routine screening tests Hai Ho, M.D.. Most expensive part of medical practice? Your Pen.
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
METABOLIC Syndrome: a Global Perspective
LESSON 2.8: BODY MASS INDEX Unit 2: Nutrition & Fitness.
Postprandial Serum Fructose Levels in Patients Tested for Diabetes Mary Beth Patterson, M.D. Pediatric Endocrinology Harbor-UCLA Medical Center.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
Hypertension, Cardiovascular Disease, Diabetes. 34% of Americans 36% of Americans.
The entwined factors Syndrome X. hypertension diabetes heart disease “trunkal” obesity cancers of all types Gene that lends predisposition to Syndrome.
VBWG Insulin Resistance and Cardiovascular Disease: New Perspectives From Vascular Biology.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
The Obesity/Diabetes Epidemic: Adiposopathy & Obesity- The New Disease! Dx & (Rx) of Insulin Resistance & early DM Part 3 Stan Schwartz MD, FACP, FACE.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Metabolic syndrome from a gender and cardiovascular perspective Eva Swahn.
Diabetes mellitus “ Basic approach” Dr Sajith.V.S MBBS,MD (Gen Med )
Chapter 15 Cardiovascular Disease Risk Factors and Physical Activity.
Sugar Coated.
Alienation and Food What’s in our food, and what does it do to us? What’s in our food, and what does it do to us?
Cardiovascular Disease (CVD) A general term for diseases of the heart and/or blood __________ _____% of all deaths annually 2,600 American deaths each.
Dr. Bryan W. Barry. Extreme Health Begins with Optimal Nutrition It’s Time to Take Charge, and the Time is NOW NOW Only YOU have to power to Achieve Your.
DIET CONTROL  All diabetic patients should be on diet control.  Diet control is a must either the patient is taking insulin or oral therapy.  Over.
LAB (6): LIPIDS PROFILE KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (Bioc 416) 2013.
P.E. PROFESSIONAL DEVELOPMENT TRAINING. WHAT ARE THE BIGGEST CONCERNS YOU HAVE ABOUT THE PHYSICAL WELL-BEING OF KIDS FROM THIS GENERATION?
INTERVENTION IS PREVENTION: For A Healthier Community Bronx County Medical Society 10 th Annual National Doctors Recognition Day March 20, 2013 Julie J.
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli,
LOW CARB, HIGH FAT ECON 4 LIN THOMPSON. KETOGENIC DIETS < 100 CARBOHYDRATES PER DAY ADKINS IS THE BEST KNOWN KETOGENIC DIET PUTS THE BODY IN KETOSIS.
Heart Health Check Up to prevent Heart Disease and live Heart-Smart Healthcheckup.com.
Note Final Exam-please check final schedule.
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Biological determinants
Cardiovascular Disease
Cardiovascular System
Oxford Niacin Trial.
Note Final Exam-please check final schedule.
Developing a Heart-Healthy Life Style
Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53
Type 2 diabetes: Overlap of clinical conditions
Note Final Exam-please check final schedule
THE ENDOCANNABINOID SYSTEM AND CARDIOMETABOLIC RISK
Description of studies for pooled analyses
Note Final Exam-please check final schedule.
Note Final Exam-please check final schedule.
Goals & Guidelines A summary of international guidelines for CHD
Why Does It Matter What We Eat?
Presentation transcript:

RISK FACTORS FOR ATHEROSCLEROSIS IN OBESE CHILDREN  Dyslipidemia High triglycerides, VLDL Low HDL High small, dense LDL  Glucose intolerance, diabetes  Hypertension

Pathobiological Determinants of Atherosclerosis in Youth Study (PDAY) Strong, et al. JAMA 281: , autopsies after trauma, age 15-34y, 9 centers 15-19y: fatty streaks in all aortas, half of coronaries More fatty streaks and advanced plaque with » high LDL, VLDL » low HDL » high blood pressure » smoking » obesity » glucose intolerance

McGill et al Am J Clin Nutr 72:1307S-15S, 2000 PDAY: Low Risk vs. High Risk Lipid Profiles

Title: Differences in Vascular Compliance in Pediatric Patients at Risk for Cardiovascular Disease as Measured by Endo-PAT Technology PI: Rubin Cooper, M.D., Dept. of Cardiology Subjects: age 8-18, 20 per group: 1) healthy controls 2) overweight (BMI>95%) 3) high cholesterol and/or triglycerides 4) fatty liver Study Design: at baseline, 6 and 12 months: 1) endo-PAT test 2) carotid artery wall thickness by ultrasound 3) fasting blood sample Pediatric Obesity Council Protocol

Does sugar make us fat, dyslipidemic and diabetic?

Duffey, K. J et al. Am J Clin Nutr 2008;88:1722S-1732S Major Sources of Calories as High-fructose Corn syrup (HFCS) and Sucrose

Nutritional Studies of: 1) Chronic effects of the equicaloric substitution of carbohydrate for fat 1) Acute effects of oral challenges with fructose

Dietary Fructose: - Does not acutely raise glucose or insulin - Raises plasma triglycerides more than glucose - Rapidly increases palmitate synthesis?

AUC TG %16:0

Hypothesis: In overweight subjects, the synthesis of palmitate from dietary fructose will be 1)greater when consumed with glucose 2)show a dose-response.

Study Design: Outpatient, random order, cross-over, single blinded study in 15 overweight subjects 1)Screening visit with 3h OGTT (75 g glucose, mean 0.9g/kg) 2)Sugar in 12 oz water, 15 min: Fructose, 0.5g/kg Fructose:Glucose 1g/kg Fructose:Glucose 2g/kg 1)Blood sampling at 0, 1, 2, 3, 4h

Lessons Learned: The equicaloric substitution of fat with sugar does not increase body fat. The equicaloric substitution of fat with sugar, fructose more than glucose, causes dyslipidemia by increasing the production of fat from sugar in the liver. The large within-subject variability in response may be partially explained by differences in insulin sensitivity. Dyslipidemia associated with obesity is readily corrected by modifications in diet and physical activity.

Some unanswered questions: 1)Does the lipogenic response to sugar predict susceptibility to diabetes, fatty liver and atherosclerosis? 2)Are there age- and family-specific differences in sugar-induced lipogenesis? 3)What are optimal levels of HFCS/sucrose in the diet? 4)What are the best ways to evaluate extent and progression of insulin resistance and atherosclerosis?

%

Elliott et al AJCN 2002, 76:911